Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.

The U.S. Department of Health and Human Services terminated billions of dollars in grants relating to COVID, HIV, infectious ...

The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...

Five years since the WHO declared Covid-19 a global pandemic, Europe is still taking stock of what’s changed and what hasn’t.

It’s difficult to predict what this year’s flu season is going to be like. But it’s a good time to start thinking about ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

Many philosophers and scientists have pondered if we live in a simulated universe, and University of Portsmouth scientist ...

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...

Pakistan's President Asif Ali Zardari, age 69, has tested positive for COVID and is currently in isolation. After ...

The first mention of Covid-19 in the Queens Chronicle came on Jan. 30, 2020, in a story headlined “Coronavirus fears seep ...

C disinfection cabinet market with its SaniUV-Cubetm, designed to quickly neutralize bacteria, mold, and viruses on many small items. It is constructed from stainless steel for extreme ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...